These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17885954)

  • 1. Evaluation of fungal and bacterial contaminations of patient-used ocular drops.
    Feghhi M; Mahmoudabadi AZ; Mehdinejad M
    Med Mycol; 2008 Feb; 46(1):17-21. PubMed ID: 17885954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial contamination of preservative free eye drops in multiple application containers.
    Rahman MQ; Tejwani D; Wilson JA; Butcher I; Ramaesh K
    Br J Ophthalmol; 2006 Feb; 90(2):139-41. PubMed ID: 16424520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial contamination of multiple-use bottles of fluorescein ophthalmic solution.
    Kyei S; France D; Asiedu K
    Clin Exp Optom; 2019 Jan; 102(1):30-34. PubMed ID: 30058164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system.
    Rosenthal RA; Buck SL; Henry CL; Schlech BA
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):440-8. PubMed ID: 17238811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial contamination of multi-use ophthalmic solutions in Kenya.
    Nentwich MM; Kollmann KH; Meshack J; Ilako DR; Schaller UC
    Br J Ophthalmol; 2007 Oct; 91(10):1265-8. PubMed ID: 17475714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contamination risk of 100% autologous serum eye drops in management of ocular surface diseases.
    Thanathanee O; Phanphruk W; Anutarapongpan O; Romphruk A; Suwan-Apichon O
    Cornea; 2013 Aug; 32(8):1116-9. PubMed ID: 23665646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an extended period of use for preserved eye drops in hospital practice.
    Livingstone DJ; Hanlon GW; Dyke S
    Br J Ophthalmol; 1998 May; 82(5):473-5. PubMed ID: 9713050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unorthodox ophthalmic preparations on the Ghanaian market: a potential risk for ocular and enteric infections.
    Kyei S; Dogbadze E; Tagoh S; Mwanza E
    Afr Health Sci; 2020 Mar; 20(1):515-523. PubMed ID: 33402940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of microbial contamination of canine plasma eyedropper bottles following clinical use in canine patients.
    Strauss RA; Genschel U; Allbaugh RA; Sebbag L; Ben-Shlomo G
    Vet Ophthalmol; 2019 May; 22(3):222-228. PubMed ID: 29797413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacterial contamination of multi-dose ocular solutions. A prospective study at the Grenoble Teaching Hospital].
    Brudieu E; Duc DL; Masella JJ; Croize J; Valence B; Meylan I; Mouillon M; Franco A; Calop J
    Pathol Biol (Paris); 1999 Dec; 47(10):1065-70. PubMed ID: 10674260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial contamination of drops and dropper tips of in-use multidose eye drop bottles.
    Høvding G; Sjursen H
    Acta Ophthalmol (Copenh); 1982 Apr; 60(2):213-22. PubMed ID: 6753455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects].
    Sauer R; Blüthner K; Seitz B
    Ophthalmologe; 2004 Jul; 101(7):705-9. PubMed ID: 14999414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial contamination of eye drops.
    Taşli H; Coşar G
    Cent Eur J Public Health; 2001 Aug; 9(3):162-4. PubMed ID: 11505742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial Contamination of Multi-dose Eye Drops at Ophthalmology Department, University of Gondar, Northwest Ethiopia.
    Tsegaw A; Tsegaw A; Abula T; Assefa Y
    Middle East Afr J Ophthalmol; 2017; 24(2):81-86. PubMed ID: 28936051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of bacterial contamination of three multidose ophthalmic solutions.
    Betbeze CM; Stiles J; Krohne SG
    Vet Ophthalmol; 2007; 10(2):81-3. PubMed ID: 17324162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial contamination of eyedrop dispensers.
    Coad CT; Osato MS; Wilhelmus KR
    Am J Ophthalmol; 1984 Nov; 98(5):548-51. PubMed ID: 6437230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial contamination rate of eyedrops: comparison of a hospital and a private outpatient center in Kermanshah, Iran.
    Jalali R; Zinolabedini F; Moradi M; Dibazar N
    Insight; 2004; 29(3):12-4. PubMed ID: 15552198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Environmental Control Experiment for Contamination of the Production and Storage of 20% Autologous Serum Eye Drops.
    Yang Y; Zhu X; Yang J; Shi A; Jiang M; Peng Y; Li M; Wang Y; Yuan H
    Curr Eye Res; 2020 Nov; 45(11):1364-1368. PubMed ID: 32150475
    [No Abstract]   [Full Text] [Related]  

  • 19. Open drops in ophthalmology offices: expiration and contamination.
    Wessels IF; Bekendam P; Calvin WS; Zimmerman GJ
    Ophthalmic Surg Lasers; 1999; 30(7):540-6. PubMed ID: 10929977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab sterility in multiple doses from a single-use vial.
    Ornek K; Karahan ZC; Ergin A; Tekeli A; Tekeli O
    Ann Pharmacother; 2008 Oct; 42(10):1425-8. PubMed ID: 18765834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.